Methods Of Treating Cognitive Impairment

Abstract

The subject invention concerns materials and methods for treating a person or animal having cognitive impairment. In one embodiment, the method comprises administering an effective amount of one or more inflammatory mediator(s), for example, fms-related tyrosine kinase 3 (Flt3) ligand, interleukin-6 (IL-6), macrophage migration inhibitory factor (MIF), interleukin-1 (IL-1), interleukin-3 (IL-3), erythropoietin (EPO), vascular endothelial growth factor A (VEGF-A), hypoxia-inducible transcription factor (HIF-1alpha), insulin like growth factor-1 (IGF-1), tumor necrosis factor (TNF), granulocyte colony-stimulating factor (G-CSF), granulocyte/macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), Stem Cell Factor (SCF), Darbepoetin (ARANESP), and metalloproteinases, to an animal or person in need of treatment.


Claims
Owners (US)

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jul 11, 2017
  • Application: Jun 4, 2015
    US US 201514730485 A
  • Priority: Jun 4, 2015
    US US 201514730485 A
  • Priority: Jun 21, 2011
    US US 201113165344 A
  • Priority: Feb 3, 2011
    US US 201113057387 A
  • Priority: Aug 4, 2009
    US US 2009/0052742 W
  • Priority: Aug 5, 2008
    US US 8635108 P

Download Citation


Sign in to the Lens

Feedback